Legal Representation
Attorney
Richard L. Kirkpatrick
USPTO Deadlines
Application History
21 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 25, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Mar 25, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Aug 21, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jun 26, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jun 26, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 6, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
May 15, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 14, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
May 14, 2018 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
May 14, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
May 14, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
May 4, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
May 3, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
May 3, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 12, 2018 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
Feb 12, 2018 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
Feb 12, 2018 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
Feb 12, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Feb 12, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Feb 7, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 6, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmacogenomics test kits comprised of reagents, diagnostic assays, swabs, test tubes, and instructional manuals for diagnostic or treatment purposes
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Pharmacogenomics testing services for diagnostic and treatment purposes; medical information services, namely, reporting of pharmacogenomics testing results directly to the health care provider
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
044